2012-10-09 00:19:02 -
Recently published research from Global Markets Direct, "FIT Biotech Oyj - Product Pipeline Review - 2012", is now available at Fast Market Research
Global Market Direct's pharmaceuticals report, "FIT Biotech Oyj - Product Pipeline Review - 2012" provides data on the FIT Biotech Oyj's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, FIT Biotech Oyj's corporate website, SEC filings, investor presentations and featured press releases, both from FIT Biotech Oyj and industry-specific third party sources, put together by Global Markets Direct's team.
Full Report Details at
- www.fastmr.com/prod/468533_fit_biotech_oyj_product_pipeline_revi ..
Scope
* FIT Biotech Oyj - Brief FIT Biotech Oyj overview including business description, key information and facts, and its locations and
subsidiaries.
* Review of current pipeline of FIT Biotech Oyj human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of FIT Biotech Oyj with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the FIT Biotech Oyj's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.
Reasons to buy
* Evaluate FIT Biotech Oyj's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of FIT Biotech Oyj in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the FIT Biotech Oyj's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with FIT Biotech Oyj.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of FIT Biotech Oyj and identify potential opportunities in those areas.
Report Table of Contents:
Table of Contents
Table of Contents
List of Tables
List of Figures
FIT Biotech Oyj Snapshot
FIT Biotech Oyj Overview
Key Information
Key Facts
FIT Biotech Oyj - Research and Development Overview
Key Therapeutic Areas
FIT Biotech Oyj - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
FIT Biotech Oyj - Pipeline Products Glance
FIT Biotech Oyj Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
FIT Biotech Oyj - Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
FIT Biotech Oyj - Drug Profiles
Dengue Fever Vaccine
Product Description
Mechanism of Action
R&D Progress
FIT-06
Product Description
Mechanism of Action
R&D Progress
FP6 TBVAC
Product Description
Mechanism of Action
R&D Progress
GTU-Nef
Product Description
Mechanism of Action
R&D Progress
Malaria Vaccine
Product Description
Mechanism of Action
R&D Progress
FIT Biotech Oyj - Dormant Projects
FIT Biotech Oyj - Locations And Subsidiaries
Head Office
FIT Biotech Oyj, Recent Developments
FIT Biotech Oyj- Press Release
May 26, 2009: ImmunoVaccine Technologies Partners With FIT Biotech To Advance A Therapeutic HIV Vaccine
Mar 29, 2009: Finnish Vaccine Technology Plays Key Role In Development Of A New Tuberculosis Vaccine
Financial Deals Landscape
FIT Biotech Oyj, Deals Summary
FIT Biotech Oyj, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
FIT Biotech Secures $6 Million In Financing
Partnerships
ImmunoVaccine Technologies Enters Into Research Agreement With FIT Biotech
FIT Biotech Enters Into Co-Development Agreement With TBVI
Debt Offering
FIT Biotech Completes Private Placement Of Convertible Notes For $5.7 Million
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
FIT Biotech Oyj, Key Information
FIT Biotech Oyj, Key Facts
FIT Biotech Oyj - Pipeline by Indication, 2012
FIT Biotech Oyj - Pipeline by Stage of Development, 2012
FIT Biotech Oyj - Monotherapy Products in Pipeline, 2012
FIT Biotech Oyj - Phase II, 2012
FIT Biotech Oyj - Discovery, 2012
FIT Biotech Oyj - Dormant Developmental Projects,2012
FIT Biotech Oyj, Deals Summary
FIT Biotech Secures $6 Million In Financing
ImmunoVaccine Technologies Enters Into Research Agreement With FIT Biotech
FIT Biotech Enters Into Co-Development Agreement With TBVI
FIT Biotech Completes Private Placement Of Convertible Notes For $5.7 Million
List of Figures
FIT Biotech Oyj - Pipeline by Indication, 2012
FIT Biotech Oyj - Pipeline by Stage of Development, 2012
FIT Biotech Oyj - Monotherapy Products in Pipeline, 2012
About Global Markets Direct
Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at
www.fastmr.com/catalog/publishers.aspx?pubid=1033
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at
www.fastmr.com or call us at 1.800.844.8156.
